Naloxone clinical trials
Also written Narcan.
Counted the way a researcher would: Naloxone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Naloxone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Naloxone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 13 Apr 1971 · NARCAN · NDA 016636 (FDA, Drugs@FDA)
- European Union
- 26 Sept 2006 · Suboxone · EMEA/H/C/000697 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Development codes
- RBP-6300
- 1
Studies by the year they started
141 studies that test it; most in 2013 (11); 2 more planned to start later
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1996 | 4 |
| 1997 | 1 |
| 1999 | 2 |
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 4 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 11 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 121
National Institute on Drug Abuse (NIDA) (14) · University of California, San Francisco (5) · New York State Psychiatric Institute (5) · Mundipharma Korea Ltd (4) · University of California, Los Angeles (4) · University of Maryland, Baltimore (3) · University of Pennsylvania (3) · Indivior Inc. (3)
Often tested with
Tested in the same studies.
Buprenorphine (56) · Oxycodone (11) · Naltrexone (5) · Methadone (4) · Methylnaltrexone (3) · Morphine (2) · Vivitrol (2) · Acetaminophen (2)
Related medicines
As reviewed, each with the page that says it.
- One of Opioid antagonists source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test Naloxone, phase 3 first.
- Jan 2027Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderPhase 2/3 · New York State Psychiatric Institute
- Jan 2027RM1 Project 1 - tAN NaloxoneEarly Phase 1 · Medical University of South Carolina
Studies
Open first, then newest update. How each study uses Naloxone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 146
- Sedation and Guided Education for Depression StudyNot yet recruitingNot applicableStanford UniversityNCT06705270Written as IV naloxoneHow we know
- Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency DepartmentsRecruitingPhase 2/3University of British ColumbiaNCT04893525Written as Buprenorphine/naloxoneHow we know
- Naloxone for Opioid Associated Out of Hospital Cardiac ArrestNot yet recruitingPhase 2University of California, San FranciscoNCT06251609Written as Naloxone 2 MGHow we know
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderRecruitingPhase 4VA Office of Research and DevelopmentNCT04375033Written as Sublingual buprenorphine with naloxoneHow we know
- Naloxone for In-Hospital Cardiac ArrestNot yet recruitingPhase 2/3Region SkaneNCT07806565Written as naloxoneHow we know
- Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderRecruitingPhase 2/3New York State Psychiatric InstituteNCT05011266Written as Buprenorphine/naloxoneHow we know
- Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility TrialRecruitingPhase 4Pouya AzarNCT07439549Written as Naloxone Hydrochloride 0.4 MG/MLHow we know
- RM1 Project 1 - tAN NaloxoneRecruitingEarly Phase 1Medical University of South CarolinaNCT05490134Written as NaloxoneHow we know
- Endogenous Opioid Response to InjectionsRecruitingPhase 4Middle Tennessee Research InstituteNCT06666621Written as Naloxone infusionHow we know
- Buprenorphine for Probationers and Parolees: Bridging the Gap Into TreatmentSuspendedPhase 3Friends Research Institute, Inc.NCT03616236Written as Buprenorphine/NaloxoneHow we know
- Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid MechanismsCompletedPhase 4Vanderbilt University Medical CenterNCT05142267Written as NaloxoneHow we know
- Reversal of Opioid-induced Respiratory Depression With Opioid AntagonistsTerminatedPhase 1Leiden University Medical CenterNCT05338632Written as Narcan 40 MG/ML Nasal SprayHow we know
- Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use FentanylActive, not recruitingPhase 3University of Maryland, BaltimoreNCT06089707Written as Naloxone Nasal SprayHow we know
- Opioid Antagonism in Hypogonadotropic HypogonadismCompletedPhase 1Stephanie B. Seminara, MDNCT04975334Written as NaloxoneHow we know
- Mechanisms of Hypoglycemia Associated Autonomic FailureTerminatedPhase 2Albert Einstein College of MedicineNCT00678145Written as naloxoneHow we know
- Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain PatientsTerminatedPhase 4Theresa Jacob, PhD, MPHNCT01841931Written as Buprenorphine/NaloxoneHow we know
- Pharmacokinetics of Intravenous and Intranasal Formulations of Naloxone in Healthy Volunteers.CompletedPhase 1Parc de Salut MarNCT06306391Written as Intravenous naloxoneHow we know
- Neural Correlates of Hypoalgesia Driven by ObservationCompletedPhase 2University of Maryland, BaltimoreNCT03897998Written as NaloxoneHow we know
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1TerminatedPhase 2University of PennsylvaniaNCT04480554Written as Buprenorphine/naloxoneHow we know
- Neural Mechanisms of Immersive Virtual Reality in Chronic PainActive, not recruitingPhase 1/2University of Maryland, BaltimoreNCT04851301Written as NaloxoneHow we know
See all 146 studies that test Naloxone →
Given beside what is tested · 20 — Naloxone is usual care or a partner of the new treatment
- Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use DisorderRecruitingPhase 2University of British ColumbiaNCT04234191Written as Buprenorphine/naloxoneHow we know
- A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone BlockadeCompletedPhase 2Clear Scientific, Inc.NCT07459166Written as Naloxone HydrochlorideHow we know
- Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back PainCompletedEarly Phase 1Rush University Medical CenterNCT04744883Written as NaloxoneHow we know
- Multi-System Analysis of Opioid Receptor BindingActive, not recruitingPhase 1University of PennsylvaniaNCT05528848Written as NaloxoneHow we know
- A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use DisorderCompletedPhase 1Astellas Pharma Global Development, Inc.NCT04447287Written as buprenorphine/naloxoneHow we know
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use DisorderWithdrawnPhase 2Astellas Pharma Global Development, Inc.NCT05062577Written as buprenorphine/naloxoneHow we know
- Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use DisorderCompletedPhase 1Indivior Inc.NCT04976855Written as SUBOXONE® sublingual filmHow we know
- Neuropeptides in Human ReproductionCompletedPhase 1Massachusetts General HospitalNCT01952782Written as NaloxoneHow we know
- Mechanism of Analgesic Effect on Prolonged Continuous Theta Burst StimulationCompletedNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05360030Written as NaloxoneHow we know
- CBT4CBT for Office Based BuprenorphineCompletedPhase 1/2CBT4CBT, LLCNCT03580902Written as Buprenorphine/naloxoneHow we know
- Medication Maintenance Therapy in Community Pharmacy SettingsStatus unknownPhase 2/3LifespanNCT04139213Written as buprenorphine/naloxone oral productHow we know
- Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.SCompletedNot applicableTanta UniversityNCT04518618Written as NaloxoneHow we know
- Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid FunctionCompletedNot applicableVanderbilt University Medical CenterNCT02469077Written as naloxoneHow we know
- A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid OverdosesCompletedNot applicableUniversity of CincinnatiNCT02922959Written as naloxone nasal spray kitHow we know
- Improving Office Based Treatment of Opioid Use Disorder With TechnologyStatus unknownNot applicableMedicaSafe, Inc.NCT03586466Written as Buprenorphine/naloxoneHow we know
- The Role of Opioidergic Systems in Breathing Based AnalgesiaCompletedEarly Phase 1University of California, San DiegoNCT03419858Written as NaloxoneHow we know
- Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid DisorderCompletedPhase 2Indivior Inc.NCT02044094Written as buprenorphine and naloxoneHow we know
- Comparison of Naloxone PharmacokineticsCompletedPhase 1National Institute on Drug Abuse (NIDA)NCT03386591Written as NaloxoneHow we know
- A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)CompletedPhase 4Indivior Inc.NCT00605033Written as Suboxone, Buprenorphine Hydrochloride + Naloxone, SCH 484How we know
- Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?Status unknownPhase 2Hanyang University Seoul HospitalNCT02307305Written as celecoxib, naproxen/esomeprazole, acetaminophen/tramadol, oxycodone/naloxoneHow we know
As the comparator · 14 — what is tested is compared with Naloxone
- Pharmacodynamic Evaluation of Intranasal NalmefeneCompletedPhase 1Opiant Pharmaceuticals IncNCT04828005Written as Naloxone hydrochlorideHow we know
- Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mgCompletedPhase 1Purdue Pharma LPNCT06719986Written as Naloxone HCl intranasalHow we know
- Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid OverdoseWithdrawnPhase 3University of New MexicoNCT06408714Written as Naloxone InjectionHow we know
- Clinical Outcomes From NalmefeneWithdrawnPhase 4Purdue Pharma LPNCT05808881Written as Naloxone Hydrochloride InjectionHow we know
- Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy VolunteersCompletedPhase 1Pocket Naloxone CorpNCT05363501Written as Naloxone Nasal SprayHow we know
- Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) AutoinjectorCompletedPhase 1PfizerNCT05264493Written as Naloxone Hydrochloride Injection, USPHow we know
- A Pilot Study of the Bioavailability of Nasal NaloxoneCompletedPhase 2Norwegian University of Science and TechnologyNCT01939444Written as naloxone intravenousHow we know
- Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the HospitalCompletedPhase 3Norwegian University of Science and TechnologyNCT03518021Written as Naloxone, intramuscularHow we know
- Comparison of Three Opioid Detoxification Treatment RegimensWithdrawnPhase 3University of Alabama at BirminghamNCT03678792Written as Buprenorphine/naloxoneHow we know
- Medications Development for Drug Abuse DisordersCompletedPhase 1/2Johns Hopkins UniversityNCT01188421Written as Buprenorphine/naloxoneHow we know
- Abuse Liability of Suboxone Versus SubutexCompletedPhase 3New York State Psychiatric InstituteNCT00710385Written as NaloxoneHow we know
- To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer PainCompletedPhase 2/3Mundipharma Research GmbH & Co KGNCT02321397Written as NaloxoneHow we know
- Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent AdolescentsWithdrawnPhase 4State University of New York at BuffaloNCT01015066Written as Buprenorphine/naloxoneHow we know
- Opioid Effects on Swallowing and Esophageal Sphincter PressureCompletedPhase 4Region Örebro CountyNCT01191645Written as naloxoneHow we know
Codes
What other systems call Naloxone · ClinicalTrials.gg INT007866
- MeSH (NLM) D009270NaloxoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 36B82AMQ7NNALOXONEConfirmed FDA, NLM, Wikidata
- RxNorm 7242Confirmed FDA, Wikidata
- Wikidata Q282902naloxoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62054NaloxoneOne source FDA
- DrugBank DB01183One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009270 | Naloxone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 36B82AMQ7N | NALOXONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7242 | — | Confirmed FDA, Wikidata |
| Wikidata | Q282902 | naloxone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62054 | Naloxone | One source FDA |
| DrugBank | DB01183 | — | One source Wikidata |
Also registered as naloxone hydrochloride (UNII F850569PQR · RxNorm 203192).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.